Product NDC: | 0093-5350 |
Proprietary Name: | Budeprion |
Non Proprietary Name: | Bupropion Hydrochloride |
Active Ingredient(s): | 150 mg/1 & nbsp; Bupropion Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-5350 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077284 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080530 |
Package NDC: | 0093-5350-56 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5350-56) |
NDC Code | 0093-5350-56 |
Proprietary Name | Budeprion |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-5350-56) |
Product NDC | 0093-5350 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bupropion Hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20080530 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | BUPROPION HYDROCHLORIDE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |